Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Pregnancy does not affect HIV incidence test results obtained using the BED capture enzyme immunoassay or an antibody avidity assay.

Laeyendecker O, Church JD, Oliver AE, Mwatha A, Owen SM, Donnell D, Brookmeyer R, Musoke P, Jackson JB, Guay L, Nakabiito C, Quinn TC, Eshleman SH.

PLoS One. 2010 Oct 11;5(10):e13259. doi: 10.1371/journal.pone.0013259.

2.

Immune responses in Ugandan women infected with subtypes A and D HIV using the BED capture immunoassay and an antibody avidity assay.

Longosz AF, Morrison CS, Chen PL, Arts E, Nankya I, Salata RA, Franco V, Quinn TC, Eshleman SH, Laeyendecker O.

J Acquir Immune Defic Syndr. 2014 Apr 1;65(4):390-6. doi: 10.1097/QAI.0000000000000006.

3.

Impact of HIV subtype on performance of the limiting antigen-avidity enzyme immunoassay, the bio-rad avidity assay, and the BED capture immunoassay in Rakai, Uganda.

Longosz AF, Serwadda D, Nalugoda F, Kigozi G, Franco V, Gray RH, Quinn TC, Eshleman SH, Laeyendecker O.

AIDS Res Hum Retroviruses. 2014 Apr;30(4):339-44. doi: 10.1089/AID.2013.0169. Epub 2013 Oct 25.

4.

Improved testing of recent HIV-1 infections with the BioRad avidity assay compared to the limiting antigen avidity assay and BED Capture enzyme immunoassay: evaluation using reference sample panels from the German Seroconverter Cohort.

Hauser A, Santos-Hoevener C, Meixenberger K, Zimmermann R, Somogyi S, Fiedler S, Hofmann A, Bartmeyer B, Jansen K, Hamouda O, Bannert N, Kuecherer C.

PLoS One. 2014 Jun 3;9(6):e98038. doi: 10.1371/journal.pone.0098038. eCollection 2014.

5.

Detection of recent HIV-1 infection using a new limiting-antigen avidity assay: potential for HIV-1 incidence estimates and avidity maturation studies.

Duong YT, Qiu M, De AK, Jackson K, Dobbs T, Kim AA, Nkengasong JN, Parekh BS.

PLoS One. 2012;7(3):e33328. doi: 10.1371/journal.pone.0033328. Epub 2012 Mar 27.

6.

Comparison among the BED capture enzyme immunoassay test and AxSYM avidity index assay for determining recent HIV infection and incidence in two Voluntary Counselling and Testing Centres in Northeast Brazil.

Salustiano DM, Lima KO, Cavalcanti AM, Diaz RS, Lacerda HR.

Braz J Infect Dis. 2014 Jul-Aug;18(4):449-53. doi: 10.1016/j.bjid.2014.03.001. Epub 2014 Apr 26.

7.

Effect of natural and ARV-induced viral suppression and viral breakthrough on anti-HIV antibody proportion and avidity in patients with HIV-1 subtype B infection.

Wendel SK, Mullis CE, Eshleman SH, Blankson JN, Moore RD, Keruly JC, Brookmeyer R, Quinn TC, Laeyendecker O.

PLoS One. 2013;8(2):e55525. doi: 10.1371/journal.pone.0055525. Epub 2013 Feb 20.

8.

Short communication: effect of short-course antenatal zidovudine and single-dose nevirapine on the BED capture enzyme immunoassay levels in HIV type 1 subtype C infection.

Wang R, Weng J, Moyo S, Pain D, Barr CD, Maruapula D, Mongwato D, Makhema J, Novitsky V, Essex M.

AIDS Res Hum Retroviruses. 2013 Jun;29(6):901-6. doi: 10.1089/AID.2012.0294. Epub 2013 Apr 19.

9.

Antibody maturation and viral diversification in HIV-infected women.

James MM, Laeyendecker O, Sun J, Hoover DR, Mullis CE, Cousins MM, Coates T, Moore RD, Kelen GD, Fowler MG, Kumwenda JJ, Mofenson LM, Kumwenda NI, Taha TE, Eshleman SH.

PLoS One. 2013;8(2):e57350. doi: 10.1371/journal.pone.0057350. Epub 2013 Feb 27.

10.

Estimated incidence and genotypes of HIV-1 among pregnant women in central Brazil.

Costa ZB, Stefani MM, de Lima YA, de Souza WV, de Siqueira Filha NT, Turchi MD, Borges WC, Filho CG, Filho JV, Minuzzi AL, Martelli CM.

PLoS One. 2013 Nov 4;8(11):e79189. doi: 10.1371/journal.pone.0079189. eCollection 2013.

11.

Performance of a limiting-antigen avidity enzyme immunoassay for cross-sectional estimation of HIV incidence in the United States.

Konikoff J, Brookmeyer R, Longosz AF, Cousins MM, Celum C, Buchbinder SP, Seage GR 3rd, Kirk GD, Moore RD, Mehta SH, Margolick JB, Brown J, Mayer KH, Koblin BA, Justman JE, Hodder SL, Quinn TC, Eshleman SH, Laeyendecker O.

PLoS One. 2013 Dec 27;8(12):e82772. doi: 10.1371/journal.pone.0082772. eCollection 2013.

12.

Assessment of recent HIV-1 infection by a line immunoassay for HIV-1/2 confirmation.

Schüpbach J, Gebhardt MD, Tomasik Z, Niederhauser C, Yerly S, Bürgisser P, Matter L, Gorgievski M, Dubs R, Schultze D, Steffen I, Andreutti C, Martinetti G, Güntert B, Staub R, Daneel S, Vernazza P.

PLoS Med. 2007 Dec;4(12):e343.

13.

Mean Recency Period for Estimation of HIV-1 Incidence with the BED-Capture EIA and Bio-Rad Avidity in Persons Diagnosed in the United States with Subtype B.

Hanson DL, Song R, Masciotra S, Hernandez A, Dobbs TL, Parekh BS, Owen SM, Green TA.

PLoS One. 2016 Apr 11;11(4):e0152327. doi: 10.1371/journal.pone.0152327. eCollection 2016.

14.

Differential specificity of HIV incidence assays in HIV subtypes A and D-infected individuals from Rakai, Uganda.

Mullis CE, Munshaw S, Grabowski MK, Eshleman SH, Serwadda D, Brookmeyer R, Nalugoda F, Kigozi G, Kagaayi J, Tobian AA, Wawer M, Gray RH, Quinn TC, Laeyendecker O.

AIDS Res Hum Retroviruses. 2013 Aug;29(8):1146-50. doi: 10.1089/AID.2012.0105. Epub 2013 May 29.

15.

Comparison of antibody responses to HIV infection in Ugandan women infected with HIV subtypes A and D.

Longosz AF, Morrison CS, Chen PL, Brand HH, Arts E, Nankya I, Salata RA, Quinn TC, Eshleman SH, Laeyendecker O.

AIDS Res Hum Retroviruses. 2015 Apr;31(4):421-7. doi: 10.1089/AID.2014.0081. Epub 2014 Nov 19.

16.

Specificity of four laboratory approaches for cross-sectional HIV incidence determination: analysis of samples from adults with known nonrecent HIV infection from five African countries.

Laeyendecker O, Brookmeyer R, Mullis CE, Donnell D, Lingappa J, Celum C, Baeten JM, Campbell MS, Essex M, de Bruyn G, Farquhar C, Quinn TC, Eshleman SH; Partners in Prevention HSV/HIV Transmission Study Team.

AIDS Res Hum Retroviruses. 2012 Oct;28(10):1177-83.

17.

Temporal trends in HIV Type 1 incidence among inner-city childbearing women in Atlanta: use of the IgG-capture BED-enzyme immunoassay.

Nesheim S, Parekh B, Sullivan K, Bulterys M, Dobbs T, Lindsay M, Cashat-Cruz M, Byers B, Lee F.

AIDS Res Hum Retroviruses. 2005 Jun;21(6):537-44.

PMID:
15989458
18.

Accurate detection of maternal antibodies to HIV in newborn whole blood dried on filter paper.

Pappaioanou M, Kashamuka M, Behets F, Mbala S, Biyela K, Davachi F, George JR, Green TA, Dondero TJ, Heyward WL, et al.

AIDS. 1993 Apr;7(4):483-8.

PMID:
8507414
19.

Investigating the utility of the HIV-1 BED capture enzyme immunoassay using cross-sectional and longitudinal seroconverter specimens from Africa.

Karita E, Price M, Hunter E, Chomba E, Allen S, Fei L, Kamali A, Sanders EJ, Anzala O, Katende M, Ketter N; IAVI Collaborative Seroprevalence and Incidence Study Team.

AIDS. 2007 Feb 19;21(4):403-8.

PMID:
17301558
20.

Identification of recent HIV infections and of factors associated with virus acquisition among pregnant women in 2004 and 2006 in Swaziland.

Bernasconi D, Tavoschi L, Regine V, Raimondo M, Gama D, Sulgencio L, Almaviva M, Galli C, Ensoli B, Suligoi B, Sukati H, Buttò S.

J Clin Virol. 2010 Jul;48(3):180-3. doi: 10.1016/j.jcv.2010.04.010.

PMID:
20537582
Items per page

Supplemental Content

Write to the Help Desk